CoronaryAtlas logo
CoronaryAtlas
Soluble CD40 ligand
Pathway / Platelet adhesion & activation

Soluble CD40 ligand

CD40LGprotein

sCD40L released from activated platelets amplifies endothelial dysfunction and platelet–leukocyte thrombotic crosstalk.

Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationalePlatelet α-granule release marker; endothelial activation and thrombosis mediator.
Also acts inEndothelial activation/erosion, Vascular inflammation
Druggability
DruggableYes
Known drugs / candidates6
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000102245

Type I vs Type II discrimination

ScoresLow-confidence (proxy)
R — rupture / Type-I
69
C — confounder / Type-II
62
A — assay feasibility
72
E — evidence strength
27
T1DI (composite)
11
Specificity differential (R−C)+7.1
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.

Assay & specimen

Validated clinical assay
Specimen
Serum or plasma
Collection tube
Sodium citrate 3.2% (light blue-top) · Serum separator (gold/red-top, SST)
Method / principle
Sandwich ELISA
Reagent / substrate
Anti-CD40L antibody pair
Platform
ELISA plate
Turnaround · availability
Research · Research

Human genetic evidence

0.023
Open Targets association (STEMI)

Literature evidence(59)

Showing 40 of 59 linked references.